FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313387314> ?p ?o ?g. }

• W4313387314 endingPage "296.e16" @default.
• W4313387314 startingPage "296.e9" @default.
• W4313387314 abstract "To characterize the clinical course and prognosis of bladder malignancies associated with prior prostate brachytherapy SUBJECTS/PATIENTS AND METHODS: We queried our institutional database for patients with bladder cancer (BC) diagnosed between January 2005 and April 2019 who had previously undergone low dose rate (LDR) prostate brachytherapy. Patients diagnosed with BC at least 1 year following LDR prostate brachytherapy with or without external beam radiation therapy were included. Clinical and disease-specific characteristics were abstracted from chart review and survival outcomes were estimated using Kaplan-Meier estimates. We compared the pathologic characteristics and prognosis of secondary BCs in our study cohort to those of BCs diagnosed after prostate cancer managed without radiation reported by the Surveillance, Epidemiology, and End Results (SEER) populational database from 2005 to 2018.Three hundred seventy-five patients were identified with combined diagnosis of prostate cancer and BC, 51 of whom met inclusion criteria in the study cohort. Median times from brachytherapy to BC diagnosis for the study and SEER cohort were 9.5 ± 4.5 and 6.3 ± 4.1 years, respectively. Compared to the SEER cohort, significantly greater proportion of BC from the study cohort presented with high-grade (study: 78.4%, SEER: 52.3%, P = 0.0008) and with MIBC (Study BC 35.3%, SEER BC: 17.5%, P = 0.0009). The study and the SEER cohort had similar 5-year overall survival (study: 67.9%, SEER: 58.0%, P = 0.1099), and 5-year cancer-specific survival (study: 81.0%, SEER: 82.8%, P = 0.5559). The 5-year progression-free survival for the study cohort was 43.7% (95% CI: 28.8-57.7).Compared to bladder cancers following prostate cancer managed without radiation, bladder malignancies following prostate LDR brachytherapy present with higher grade and are more likely to be muscle invasive. Despite the aggressive presenting features of postprostate brachytherapy BC, there were no differences in overall and cancer-specific survival between the groups." @default.
• W4313387314 created "2023-01-06" @default.
• W4313387314 creator A5003403373 @default.
• W4313387314 creator A5008857530 @default.
• W4313387314 creator A5012665897 @default.
• W4313387314 creator A5019846014 @default.
• W4313387314 creator A5036068302 @default.
• W4313387314 creator A5040933999 @default.
• W4313387314 creator A5055425420 @default.
• W4313387314 creator A5078152404 @default.
• W4313387314 creator A5084116946 @default.
• W4313387314 date "2023-06-01" @default.
• W4313387314 modified "2023-10-16" @default.
• W4313387314 title "Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer" @default.
• W4313387314 cites W1996617584 @default.
• W4313387314 cites W2016041137 @default.
• W4313387314 cites W2062149894 @default.
• W4313387314 cites W2077881463 @default.
• W4313387314 cites W2084970306 @default.
• W4313387314 cites W2126411240 @default.
• W4313387314 cites W2136012690 @default.
• W4313387314 cites W2138396776 @default.
• W4313387314 cites W2144953456 @default.
• W4313387314 cites W2155241881 @default.
• W4313387314 cites W2165662398 @default.
• W4313387314 cites W2294907556 @default.
• W4313387314 cites W2443056117 @default.
• W4313387314 cites W2479028831 @default.
• W4313387314 cites W2613713111 @default.
• W4313387314 cites W2783003100 @default.
• W4313387314 cites W2891387610 @default.
• W4313387314 cites W2945522282 @default.
• W4313387314 cites W2946842905 @default.
• W4313387314 cites W2988045315 @default.
• W4313387314 cites W2998819711 @default.
• W4313387314 cites W3173076962 @default.
• W4313387314 cites W4251857011 @default.
• W4313387314 doi "https://doi.org/10.1016/j.urolonc.2022.12.007" @default.
• W4313387314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36588020" @default.
• W4313387314 hasPublicationYear "2023" @default.
• W4313387314 type Work @default.
• W4313387314 citedByCount "0" @default.
• W4313387314 crossrefType "journal-article" @default.
• W4313387314 hasAuthorship W4313387314A5003403373 @default.
• W4313387314 hasAuthorship W4313387314A5008857530 @default.
• W4313387314 hasAuthorship W4313387314A5012665897 @default.
• W4313387314 hasAuthorship W4313387314A5019846014 @default.
• W4313387314 hasAuthorship W4313387314A5036068302 @default.
• W4313387314 hasAuthorship W4313387314A5040933999 @default.
• W4313387314 hasAuthorship W4313387314A5055425420 @default.
• W4313387314 hasAuthorship W4313387314A5078152404 @default.
• W4313387314 hasAuthorship W4313387314A5084116946 @default.
• W4313387314 hasConcept C107130276 @default.
• W4313387314 hasConcept C121608353 @default.
• W4313387314 hasConcept C126322002 @default.
• W4313387314 hasConcept C126894567 @default.
• W4313387314 hasConcept C143998085 @default.
• W4313387314 hasConcept C201903717 @default.
• W4313387314 hasConcept C2776235491 @default.
• W4313387314 hasConcept C2777416452 @default.
• W4313387314 hasConcept C2780192828 @default.
• W4313387314 hasConcept C509974204 @default.
• W4313387314 hasConcept C71924100 @default.
• W4313387314 hasConcept C72563966 @default.
• W4313387314 hasConceptScore W4313387314C107130276 @default.
• W4313387314 hasConceptScore W4313387314C121608353 @default.
• W4313387314 hasConceptScore W4313387314C126322002 @default.
• W4313387314 hasConceptScore W4313387314C126894567 @default.
• W4313387314 hasConceptScore W4313387314C143998085 @default.
• W4313387314 hasConceptScore W4313387314C201903717 @default.
• W4313387314 hasConceptScore W4313387314C2776235491 @default.
• W4313387314 hasConceptScore W4313387314C2777416452 @default.
• W4313387314 hasConceptScore W4313387314C2780192828 @default.
• W4313387314 hasConceptScore W4313387314C509974204 @default.
• W4313387314 hasConceptScore W4313387314C71924100 @default.
• W4313387314 hasConceptScore W4313387314C72563966 @default.
• W4313387314 hasIssue "6" @default.
• W4313387314 hasLocation W43133873141 @default.
• W4313387314 hasLocation W43133873142 @default.
• W4313387314 hasOpenAccess W4313387314 @default.
• W4313387314 hasPrimaryLocation W43133873141 @default.
• W4313387314 hasRelatedWork W1980245127 @default.
• W4313387314 hasRelatedWork W2048085960 @default.
• W4313387314 hasRelatedWork W2062703397 @default.
• W4313387314 hasRelatedWork W2127440557 @default.
• W4313387314 hasRelatedWork W2165532162 @default.
• W4313387314 hasRelatedWork W2590008096 @default.
• W4313387314 hasRelatedWork W2810968949 @default.
• W4313387314 hasRelatedWork W2897445903 @default.
• W4313387314 hasRelatedWork W2999207890 @default.
• W4313387314 hasRelatedWork W3082324229 @default.
• W4313387314 hasVolume "41" @default.
• W4313387314 isParatext "false" @default.
• W4313387314 isRetracted "false" @default.
• W4313387314 workType "article" @default.